M. Kollind

745 total citations
30 papers, 608 citations indexed

About

M. Kollind is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, M. Kollind has authored 30 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in M. Kollind's work include Diabetes Management and Research (19 papers), Pancreatic function and diabetes (12 papers) and Metabolism, Diabetes, and Cancer (7 papers). M. Kollind is often cited by papers focused on Diabetes Management and Research (19 papers), Pancreatic function and diabetes (12 papers) and Metabolism, Diabetes, and Cancer (7 papers). M. Kollind collaborates with scholars based in Sweden, Norway and United Kingdom. M. Kollind's co-authors include Erik Moberg, P. E. Lins, Ulf Adamson, U. Adamson, Ian Macdonald, Per‐Eric Lins, Valdemar Grill, Elisabeth Qvigstad, Stian Lydersen and Tom‐Harald Edna and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetologia.

In The Last Decade

M. Kollind

30 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Kollind Sweden 13 361 208 138 126 124 30 608
Patrick J. Boyle United States 12 288 0.8× 117 0.6× 101 0.7× 69 0.5× 81 0.7× 20 465
M. McAloon-Dyke United States 6 363 1.0× 188 0.9× 41 0.3× 131 1.0× 93 0.8× 7 497
Maurizio Capelli Italy 14 463 1.3× 103 0.5× 62 0.4× 136 1.1× 143 1.2× 28 779
Clara Gomez-Sanchez United States 12 209 0.6× 180 0.9× 71 0.5× 96 0.8× 122 1.0× 29 660
Jesse Chou United States 13 245 0.7× 244 1.2× 48 0.3× 141 1.1× 109 0.9× 37 691
Friederike Schulze Switzerland 10 202 0.6× 295 1.4× 217 1.6× 221 1.8× 151 1.2× 13 820
G. Brisson Canada 13 122 0.3× 212 1.0× 131 0.9× 117 0.9× 123 1.0× 35 595
A. M. Rambotti Italy 9 682 1.9× 353 1.7× 262 1.9× 107 0.8× 118 1.0× 13 853
R. Rizza United States 12 484 1.3× 212 1.0× 79 0.6× 236 1.9× 267 2.2× 14 760
Irene E. Schauer United States 17 518 1.4× 239 1.1× 188 1.4× 199 1.6× 217 1.8× 37 951

Countries citing papers authored by M. Kollind

Since Specialization
Citations

This map shows the geographic impact of M. Kollind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kollind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kollind more than expected).

Fields of papers citing papers by M. Kollind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Kollind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kollind. The network helps show where M. Kollind may publish in the future.

Co-authorship network of co-authors of M. Kollind

This figure shows the co-authorship network connecting the top 25 collaborators of M. Kollind. A scholar is included among the top collaborators of M. Kollind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Kollind. M. Kollind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grill, Valdemar, Maria Radtke, Elisabeth Qvigstad, M. Kollind, & Anneli Björklund. (2009). Beneficial effects of K‐ATP channel openers in diabetes: an update on mechanisms and clinical experiences. Diabetes Obesity and Metabolism. 11(s4). 143–148. 16 indexed citations
2.
Kollind, M., et al.. (2008). Diabetes mellitus and outcomes of colorectal cancer. Acta Oncologica. 48(3). 361–367. 46 indexed citations
3.
Radtke, Maria, M. Kollind, Elisabeth Qvigstad, & Valdemar Grill. (2007). Twelve weeks’ treatment with diazoxide without insulin supplementation in Type 2 diabetes is feasible but does not improve insulin secretion. Diabetic Medicine. 24(2). 172–177. 10 indexed citations
4.
Qvigstad, Elisabeth, M. Kollind, & Valdemar Grill. (2003). Nine weeks of bedtime diazoxide is well tolerated and improves β‐cell function in subjects with Type 2 diabetes. Diabetic Medicine. 21(1). 73–76. 22 indexed citations
5.
Kollind, M., et al.. (2002). Ovarian Ultrasound and Ovarian and Adrenal Hormones before and after Treatment for Hyperthyroidism. Gynecologic and Obstetric Investigation. 54(1). 50–55. 15 indexed citations
6.
Moberg, Erik, et al.. (1996). Acute effects of the alpha 2-adrenoreceptor antagonist idazoxan on hormonal responses and symptoms of hypoglycaemia in patients with type 1 diabetes mellitus.. PubMed. 22(1). 31–6. 4 indexed citations
7.
Moberg, Erik, et al.. (1995). Day‐to‐day Variation of Insulin Sensitivity in Patients with Type 1 Diabetes: Role of Gender and Menstrual Cycle. Diabetic Medicine. 12(3). 224–228. 35 indexed citations
8.
Moberg, Erik, M. Kollind, P. E. Lins, & Ulf Adamson. (1994). Acute mental stress impairs insulin sensitivity in IDDM patients. Diabetologia. 37(3). 247–251. 49 indexed citations
9.
Moberg, Erik, et al.. (1993). Estimation of blood-glucose variability in patients with insulin-dependent diabetes mellitus. Scandinavian Journal of Clinical and Laboratory Investigation. 53(5). 507–514. 37 indexed citations
10.
Moberg, Erik, et al.. (1993). Estimation of blood-glucose variability in patients with insulin-dependent diabetes mellitus. Scandinavian Journal of Clinical and Laboratory Investigation. 53(5). 507–514. 13 indexed citations
11.
12.
Roll, M., M. Kollind, & Töres Theorell. (1992). Five‐year follow‐up of young adults visiting an emergency unit because of atypical chest pain. Journal of Internal Medicine. 231(1). 59–65. 28 indexed citations
13.
Kollind, M., et al.. (1991). Insulin Clearance During Hypoglycemia in Patients with Insulin-Dependent Diabetes Mellitus. Hormone and Metabolic Research. 23(7). 333–335. 2 indexed citations
14.
Roll, M., M. Kollind, & Töres Theorell. (1991). Clinical symptoms in young adults with atypical chest pain attending the emergency department. Journal of Internal Medicine. 230(3). 271–277. 6 indexed citations
15.
Kollind, M., Erik Moberg, P. E. Lins, & U. Adamson. (1990). Exogenous Somatostatin Raises Plasma Insulin Levels in Patients with Insulin-Dependent Diabetes Mellitus. Hormone and Metabolic Research. 22(11). 581–583. 6 indexed citations
16.
Kollind, M., Ulf Adamson, & Per‐Eric Lins. (1988). Studies of Insulin Resistance Following Hypoglycemia in Insulin‐dependent Diabetes Mellitus. Acta Medica Scandinavica. 223(2). 153–157. 3 indexed citations
17.
Kollind, M., Ulf Adamson, P. E. Lins, & Bertil Hamberger. (1988). Transient insulin resistance following infusion of adrenaline in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 31(8). 603–606. 6 indexed citations
18.
Kollind, M., Ulf Adamson, & P. E. Lins. (1988). Somatostatin reduces posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus. European Journal of Endocrinology. 118(2). 173–178. 7 indexed citations
19.
Kollind, M., Ulf Adamson, Per‐Eric Lins, & Tore Curstedt. (1988). Importance of Growth Hormone for Blood Glucose Regulation Following Insulin‐induced Nocturnal Hypoglycemia in Insulin‐dependent Diabetes Mellitus. Acta Medica Scandinavica. 223(2). 159–164. 9 indexed citations
20.
Kollind, M., Ulf Adamson, & P. E. Lins. (1987). Insulin resistance following nocturnal hypoglycaemia in insulin-dependent diabetes mellitus. European Journal of Endocrinology. 116(2). 314–320. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick J. Boyle Breakdown of academic impact, for papers by M. McAloon-Dyke Breakdown of academic impact, for papers by Maurizio Capelli Breakdown of academic impact, for papers by Clara Gomez-Sanchez Breakdown of academic impact, for papers by Jesse Chou Breakdown of academic impact, for papers by Friederike Schulze Breakdown of academic impact, for papers by G. Brisson Breakdown of academic impact, for papers by A. M. Rambotti Breakdown of academic impact, for papers by R. Rizza Breakdown of academic impact, for papers by Irene E. Schauer
Rankless by CCL
2026